Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Rybkarybka Rybkarybka Merchant
Oct 7, 2021 $52.61 -1.88% $53.62 X 98.12% 1
Rybkarybka Rybkarybka Merchant
Oct 5, 2021 $55.55 -2.83% $57.17 X 97.17% 1
JS JS Pro
Oct 4, 2021 $58.94 +8.53% $54.31 X 91.47% 1
AlexVel AlexVel Pro
Oct 4, 2021 $59.16 +8.93% $54.31 X 91.07% 1
Rybkarybka Rybkarybka Merchant
Oct 4, 2021 $58.90 +8.45% $54.31 X 91.55% 1
Rybkarybka Rybkarybka Merchant
Oct 1, 2021 $61.17 +1.07% $60.52 X 98.93% 2
JS JS Pro
Sep 30, 2021 $59.33 -4.43% $62.08 X 95.57% 1
Rybkarybka Rybkarybka Merchant
Sep 30, 2021 $58.65 -5.53% $62.08 X 94.47% 1
AlexVel AlexVel Pro
Sep 24, 2021 $61.89 -0.08% $61.94 X 99.92% 10
JS JS Pro
Sep 24, 2021 $63.57 +2.63% $61.94 X 97.37% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE